Veralipride

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Veralipride
Veralipride.svg
Ball-and-stick model of the veralipride molecule
Clinical data
Trade names Agreal, Agradil
Routes of
administration
Oral
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ECHA InfoCard 100.060.376
Chemical and physical data
Formula C17H25N3O5S
Molar mass 383.4625 g/mol
3D model (Jmol)
 NYesY (what is this?)  (verify)

Veralipride (Agreal, Agradil) is a benzamide neuroleptic medicine indicated in the treatment of vasomotor symptoms associated with the menopause. It was first authorised for use in 1979. Veralipride has never gained approval in the United States.

In September 2006, it was withdrawn from the Spanish market. As a result, the European Commission referred the matter to the European Medicines Agency (EMA). On July 2007, the EMA recommended the withdrawal of marketing authorisations for veralipride.[1]

See also[edit]

References[edit]